STATE STREET CORP - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 136 filers reported holding CYTOKINETICS INC in Q4 2018. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$155,386,358
-6.4%
5,274,486
+3.6%
0.01%0.0%
Q2 2023$166,087,340
-0.7%
5,091,580
+7.1%
0.01%0.0%
Q1 2023$167,289,741
-63.8%
4,753,900
-52.9%
0.01%
-35.7%
Q4 2022$462,315,918
+124.2%
10,089,828
+137.1%
0.01%
+7.7%
Q3 2022$206,161,000
+16.5%
4,255,125
-5.5%
0.01%
+18.2%
Q2 2022$176,971,000
+14.6%
4,504,226
+7.3%
0.01%
+37.5%
Q1 2022$154,485,000
-15.0%
4,196,832
+5.3%
0.01%
-11.1%
Q4 2021$181,647,000
+17.9%
3,985,227
-7.5%
0.01%
+12.5%
Q3 2021$154,050,000
+83.1%
4,310,288
+1.4%
0.01%
+100.0%
Q2 2021$84,123,000
-12.7%
4,250,786
+2.6%
0.00%
-33.3%
Q1 2021$96,342,000
-0.1%
4,141,970
-10.8%
0.01%0.0%
Q4 2020$96,438,000
+17.8%
4,640,923
+22.8%
0.01%0.0%
Q3 2020$81,843,000
+14.2%
3,780,260
+24.3%
0.01%
+20.0%
Q2 2020$71,677,000
+126.4%
3,041,032
+13.2%
0.01%
+66.7%
Q1 2020$31,663,000
+17.5%
2,685,562
+5.7%
0.00%
+50.0%
Q4 2019$26,947,000
+2.0%
2,539,766
+9.4%
0.00%0.0%
Q3 2019$26,412,000
-2.8%
2,320,879
-4.0%
0.00%0.0%
Q2 2019$27,186,000
+64.6%
2,416,514
+18.3%
0.00%
+100.0%
Q1 2019$16,520,000
+36.4%
2,042,077
+6.6%
0.00%0.0%
Q4 2018$12,109,000
-38.6%
1,915,962
-4.3%
0.00%
-50.0%
Q3 2018$19,717,000
+16.1%
2,001,562
-2.1%
0.00%
+100.0%
Q2 2018$16,978,000
-0.2%
2,045,301
-13.4%
0.00%0.0%
Q1 2018$17,005,000
-23.2%
2,361,612
-13.0%
0.00%
-50.0%
Q4 2017$22,139,000
-16.8%
2,715,972
+48.0%
0.00%0.0%
Q3 2017$26,615,000
+31.4%
1,835,515
+9.6%
0.00%0.0%
Q2 2017$20,259,000
+69.1%
1,674,335
+79.6%
0.00%
+100.0%
Q1 2017$11,981,000
+9.8%
932,426
+3.9%
0.00%0.0%
Q4 2016$10,908,000
+22.1%
897,748
-7.8%
0.00%0.0%
Q3 2016$8,936,000
+51.2%
973,200
+56.2%
0.00%0.0%
Q2 2016$5,911,000
+53.7%
623,246
+14.3%
0.00%
Q1 2016$3,845,000
-54.1%
545,460
-31.9%
0.00%
-100.0%
Q4 2015$8,380,000
+127.2%
801,211
+45.4%
0.00%
Q3 2015$3,689,000
-0.1%
551,038
+0.3%
0.00%
Q2 2015$3,694,000
+1.8%
549,615
+2.7%
0.00%
Q1 2015$3,629,000
-11.0%
535,333
+5.1%
0.00%
Q4 2014$4,079,000
+129.5%
509,167
+1.1%
0.00%
Q3 2014$1,777,000
-24.7%
503,490
+2.1%
0.00%
Q2 2014$2,360,000
-49.2%
493,368
+0.9%
0.00%
-100.0%
Q1 2014$4,648,000
+72.1%
489,174
+9.2%
0.00%
Q4 2013$2,701,000
-5.9%
447,932
+18.6%
0.00%
Q3 2013$2,869,000
-14.1%
377,687
+30.8%
0.00%
Q2 2013$3,340,000288,7340.00%
Other shareholders
CYTOKINETICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
RP Management, LLC 875,656$5,534,0003.79%
BVF INC/IL 4,150,639$26,232,0003.43%
GREAT POINT PARTNERS LLC 3,173,288$20,055,0002.54%
DAFNA Capital Management LLC 185,826$1,174,0000.58%
IRONWOOD INVESTMENT MANAGEMENT LLC 90,783$574,0000.53%
Foresite Capital Management IV, LLC 175,148$1,107,0000.51%
LANSDOWNE PARTNERS (UK) LLP 2,647,981$16,735,0000.25%
WASATCH ADVISORS LP 2,456,805$15,527,0000.21%
PINNACLE ASSOCIATES LTD 592,778$3,746,0000.10%
South Dakota Investment Council 895,316$7,238,0000.08%
View complete list of CYTOKINETICS INC shareholders